MedTrace Logo

Nd-YAG Laser Versus Epidermal Growth Factor For Myogenic Tempromandibular Disorder.

NCT06044974 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2024-08-01

No results posted yet for this study

Summary

A clinical trial comparing the potential effect of 2 different modalities (Nd-YAG Laser Versus Epidermal growth factor injection) on pain reduction in patients suffering from myogenic tempromandibular disorder.

Conditions

  • Temporomandibular Joint Disorders

Interventions

DEVICE

Nd-YAG Fotona

four combined therapy sessions using 1064 nm Nd-YAG laser (once/week)

DRUG

Epidermal Growth Factor

Epidermal growth factor "EGF-genesis" by Dermaquel Paris n into masseter and temporalis muscles. Each muscle will be divided into 3 zones; origin, body and insertion for masseter muscle, anterior, middle, and posterior for temporalis muscle

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-21
Primary Completion
2023-08-10
Completion
2024-01-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06044974 on ClinicalTrials.gov